发明申请
US20100093604A1 Gpr43 and modulators thereof for the treatment of metabolic-related disorders
有权
Gpr43及其调节剂用于治疗代谢相关疾病
- 专利标题: Gpr43 and modulators thereof for the treatment of metabolic-related disorders
- 专利标题(中): Gpr43及其调节剂用于治疗代谢相关疾病
-
申请号: US11663370申请日: 2005-09-21
-
公开(公告)号: US20100093604A1公开(公告)日: 2010-04-15
- 发明人: James N. Leonard , Yaron Hakak
- 申请人: James N. Leonard , Yaron Hakak
- 申请人地址: US CA San Diego
- 专利权人: Arena Pharmaceuticals, Inc.
- 当前专利权人: Arena Pharmaceuticals, Inc.
- 当前专利权人地址: US CA San Diego
- 国际申请: PCT/US05/33795 WO 20050921
- 主分类号: A61K38/28
- IPC分类号: A61K38/28 ; G01N33/53 ; C07K14/62 ; A61P3/10
摘要:
The present invention relates to a method for identifying a metabolic stabilizing compound by: a) contacting a candidate compound with GPR43, and b) determining whether GPR43 functionality is modulated, where a modulation in GPR43 functionality is indicative of the candidate compound being a metabolic stabilizing compound. In addition, the invention relates to a method for identifying a metabolic stabilizing compound, comprising: a) contacting a candidate compound with GPR43, and b) determining whether GPR43 functionality is increased, wherein an increase in GPR43 functionality is indicative of the candidate compound being a metabolic stabilizing compound. Further, the invention relates to a method for identifying a metabolic stabilizing compound, comprising: a) contacting a candidate compound with GPR43, and b) determining whether GPR43 functionality is decreased, wherein a decrease in GPR43 functionality is indicative of the candidate compound being a metabolic stabilizing compound.
公开/授权文献
信息查询
IPC分类: